Fiduciary Alliance’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.7K Sell
14,100
-150
-1% -$659 0.01% 501
2026
Q2
$54.9K Sell
14,250
-1,600
-10% -$5.84K ﹤0.01% 534
2026
Q1
$61.5K Hold
15,850
– – ﹤0.01% 544
2025
Q4
$107K Hold
15,850
– – 0.01% 498
2025
Q3
$111K Sell
15,850
-800
-5% -$5.56K 0.01% 487
2025
Q2
$102K Hold
16,650
– – 0.01% 474
2025
Q1
$127K Hold
16,650
– – 0.01% 376
2024
Q4
$160K Buy
+16,650
New +$130K 0.02% 342
2023
Q3
– Sell
-200
Closed -$1.32K – 628
2023
Q2
$1.32K Buy
+200
New +$1.02K ﹤0.01% 836
2023
Q1
– Sell
-200
Closed -$556 – 561
2022
Q4
$556 Buy
+200
New +$598 ﹤0.01% 841

Other funds holding MDXG

Fiduciary Alliance's MDXG Position: Q3 2026 in Review

Fiduciary Alliance reduced its MiMedx Group (MDXG) stake by 1.1% in Q3 2026, selling an estimated $659 and leaving 14,100 shares worth $65.7K. The position accounts for 0.01% of the portfolio, ranked #501.

Fiduciary Alliance first reported a position in MDXG in Q4 2022 and has held it in 10 quarters since. The position peaked at $160K in Q4 2024. 33 funds tracked by Wall St. Rank hold MDXG as of Q3 2026.

  • Fiduciary Alliance held 14,100 shares of MiMedx Group worth $65.7K as of Q3 2026.
  • Fiduciary Alliance sold 150 MiMedx Group shares in Q3 2026, an estimated $659.
  • MiMedx Group made up 0.01% of Fiduciary Alliance's portfolio in Q3 2026, its #501 holding.
  • Fiduciary Alliance first reported a position in MiMedx Group in Q4 2022 and has held it in 10 quarters since.
  • Fiduciary Alliance's MiMedx Group position peaked at $160K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.